BSE filing, NSE: BALRAMCHIN. Summary written from the filing by ALFA Finder's alert engine.
Balrampur Chini Mills Ltd: key numbers
- Share price
- ₹599.90
- Market cap
- ₹12,696 Cr
- Revenue (annual)
- ₹6,271 Cr
- Net profit (annual)
- ₹378.5 Cr
- P/E (TTM)
- 34.2×Sector 22.8×
- Promoter holding
- 42.79%-0.07% QoQ
- FII holding
- 8.96%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Balrampur Chini Mills Ltd
All →Balrampur Chini Mills Board Meeting Date
Balrampur Chini Mills will hold a board meeting on 4 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The board will also consider an interim dividend for FY 2026-27.
Balrampur Chini Mills Employee Stock Options
Balrampur Chini Mills Limited has granted 1,21,268 Employee Stock Appreciation Rights (ESARs) under its 2023 ESAR plan, with an exercise price of ₹721.25 per unit.
Balrampur Chini Mills Other Announcement
Balrampur Chini Mills Ltd has submitted its quarterly shareholding pattern report for the quarter ended September 30, 2026, in compliance with SEBI Regulation 31.
Balrampur Chini Mills Annual General Meeting
Balrampur Chini Mills Limited held its 50th Annual General Meeting on September 16, 2026. The meeting approved the financial statements and the final dividend.
Balrampur Chini Mills Other Announcement
Balrampur Chini Mills has sent a reminder intimation to physical shareholders, requesting them to update their KYC details and claim unpaid dividends or shares as mandated.
Balrampur Chini Mills Business Update
BCML received a ₹75 Crore BioE3 grant from BIRAC/DBT for a 100 TPA PLA R&D facility at Kumbhi, UP. It will advance India's biopolymer innovation and commercialisation.
- Value
- ₹75.00 Cr
- From
- BIRAC / Department of Biotechnology, Government of India
- PLA Co-Polymer R&D facility capacity
- 100 TPA
Other fund raise announcements
All →Jindal Capital Fund Raise of ₹16.22 Cr
Jindal Capital's board approved a rights issue of 1,08,12,149 shares at Rs.15 each, raising Rs.16.22 Crore. The issue ratio is 3:2, with record date 06 November 2026.
- Value
- ₹16.22 Cr
Rajkot Investment Trust Fund Raise of ₹48 Cr
Rajkot Investment Trust's board approved a Rs 48 Crore rights issue of equity shares. Pricing and record date will be set later by a committee.
- Value
- ₹48.00 Cr
U Y Fincorp Fund Raise of ₹187.2 Cr
U.Y. Fincorp's board approved preferential issues of warrants and equity shares aggregating Rs 187.17 Crore. The issue is subject to shareholder and regulatory approvals.
- Value
- ₹187.2 Cr
Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr